Burkitt Lymphoma Treatment: Advances and Approaches
Burkitt lymphoma is a rare but aggressive form of non-Hodgkin lymphoma that primarily affects B-cells. It is characterized by rapid growth and can involve lymph nodes, the jaw, gastrointestinal tract, and central nervous system. Early detection and prompt treatment are crucial due to the disease’s fast progression. Understanding the available Burkitt lymphoma treatment options can help patients and caregivers make informed decisions.
Understanding Burkitt Lymphoma
Burkitt lymphoma is more commonly seen in children and young adults, although it can occur at any age. It is classified into three main types: endemic, sporadic, and immunodeficiency-associated. Endemic Burkitt lymphoma is prevalent in parts of Africa and is often linked with the Epstein-Barr virus. Sporadic cases are more common in Western countries, while immunodeficiency-associated cases are usually observed in individuals with HIV infection. Despite the differences, treatment strategies are largely similar across these subtypes.
Standard Treatment Options
